Prosztatarák: vizsgálatok itt: Argentína

In Argentína 12 Also abroad 1480

12 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Where
Buenos Aires, Caba, Ciudad Autónoma de Buenos Aires, Córdoba, La Rioja
Életkor
18 év and over
People
430 worldwide
Run by
Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00
3. fázisTaking people
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Where
Buenos Aires, Ciudad Autónoma de Buenos Aires, Mar del Plata, Mendoza, Rosario
Életkor
18 év and over
People
1310 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00
3. fázisTaking people
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Where
Buenos Aires, CABA, Capital, Capital Federal, Córdoba, Mar del Plata
Életkor
18 év and over
People
900 worldwide
Run by
Pfizer
See details and how to joinNCT06629779 · EU 2024-511652-40-00
3. fázisTaking people
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Where
Berazategui, CABA, La Rioja, Mar del Plata, Mendoza, Rosario, Salta, San Juan
Életkor
18 év and over
People
1440 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00
No phaseNot yet taking people in Argentína
Multiparametric Magnetic Resonance Imaging (mpMRI) Versus Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) for Detecting Clinically Significant Prostate Cancer in Transition Zone Lesions /PRostate Imaging With MRI and PET in the Transition Zone (PRIME-TZ)
Where
Santa Fe
People
65
Run by
Sanatorio Privado San Geronimo
See details and how to joinNCT07892378
3. fázisTaking people
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Where
CABA
Életkor
18 év to 100 év
People
450 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05939414 · EU 2022-502956-29-00
3. fázisTaking people
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Where
CABA, Ciudad de Buenos Aires, Córdoba, Cuidad Autónoma de Buenos Aire, La Plata, Pergamino, Rosario, San Miguel de Tucumán, Viedma
Életkor
18 év and over
People
700 worldwide
Run by
AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00
3. fázisTaking people
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Where
Buenos Aires, Ciudad Autonoma de Buenos Aires, Mar del Plata, Pergamino, Rosario
Életkor
18 év and over
People
1000 worldwide
Run by
Pfizer
See details and how to joinNCT07028853 · EU 2024-519369-24-00
1/2. fázisTaking people
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Where
Ciudad Autónoma de Buenos Aires, La Rioja
Életkor
18 év and over
People
360 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06863272 · EU 2024-516036-94-00
No phaseNot yet taking people in Argentína
VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY
Where
Rio Grande
Életkor
18 év and over
People
150
Run by
Marcelo Ruben Oliva
See details and how to joinNCT07753356
No phaseTaking people
The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
Where
Rosario
Életkor
40 év to 75 év
People
6000 worldwide
Run by
Javier Toledo
See details and how to joinNCT06717295
2. fázisTaking people
Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)
Where
Buenos Aires
Életkor
18 év and over
People
60 worldwide
Run by
SMED Clinical Research
See details and how to joinNCT07299292